Presentations at international conferences

By IU Simon Comprehensive Cancer Center
Dec. 5, 2025

Indiana University Melvin and Bren Simon Comprehensive Cancer Center researchers are sharing their findings at several international conferences this fall.

The 2025 American Society of Hematology (ASH) Annual Meeting will take place Dec. 6-9 in Orlando. The world’s largest hematology event, ASH brings together more than 30,000 hematology professionals.

More than 40 abstracts including IU Simon Comprehensive Cancer Center researchers were selected for the meeting.

Highlights include:

• Attaya Suvannasankha, MD, will present “Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial” during an oral abstract session at 10:15 a.m. ET Saturday, Dec. 6.
• Rita Assi, MD; Enze Liu, PhD; James Ropa, PhD; and Suvannasankha are all presenting abstracts during poster sessions.
• Cancer center trainees Van Anh Do-Thi, Sarah Gutch, Farnaz Razmkhah and Christopher Schorr all received a 2025 Abstract Achievement Award and will present posters. According to ASH, these merit-based awards “acknowledge the accomplishments of hematologists-in-training.”

Additional cancer center researchers with findings included in the poster sessions include Lionel Apetoh, PhD; Sandeep Batra, MD; Jennifer Belsky, DO; Maegan Capitano, PhD; Larry Cripe, MD; Magdalena Czader, MD, PhD; Utpal Dave, MD; Leng Han, PhD; Emily Hopewell, PhD; Stephanie Hurwitz, MD, PhD; Travis Johnson, PhD; Mark Kaplan, PhD; Kelvin Lee, MD; Daniel Peltier, MD, PhD; April Rahrig, DO; Martin Richer, PhD; Michael Robertson, MD; Huda Salman, MD, PhD; Amanda Saraf, DO; Jennifer Schwartz, MD; Jodi Skiles, MD; and Terry Vik, MD. Katharine Head, PhD, assistant director of the cancer center’s Office of Community Outreach and Engagement, is among authors on poster session abstracts. Cancer center trainees Asif Adil, Malak Khalife, Molly Lumnitzer, Jessica Newton, and Jimin Park are also authors on poster session abstracts.

Cancer center researchers will share their findings and expertise at the 2025 San Antonio Breast Cancer Symposium, the most influential and largest gathering of breast cancer researchers and physicians in the world.

The symposium, taking place Dec. 9-12 in San Antonio, is expecting to bring together more than 10,000 attendees from more than 100 countries.

Research from the IU Simon Comprehensive Cancer Center and the Vera Bradley Foundation Center for Breast Cancer Research at the IU Simon Comprehensive Cancer Center is part of one general session and several poster sessions. Cancer center researchers are authors on 15 abstracts selected for this year’s meeting.

 Cancer center highlights include:

• Kathy Miller, MD, is among the authors of “Tumor infiltrating lymphocytes (TILs) and pathologic complete response (pCR) in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): secondary results from the ECOG-ACRIN EA1181/CompassHER2 pCR trial,” which will be presented during a general session on Dec. 10. Miller is also among authors on two abstracts selected for rapid fire oral sessions.
• Tarah Ballinger, MD, will present “Patient-reported measures of taxane-induced peripheral neuropathy (TIPN) and risk of dose reductions or worsening quality of life in Black women with breast cancer: analysis from ECOG-ACRIN EAZ171” during poster session 1 on Dec. 10.
• Hari Nakshatri, PhD, will present “Tonsl, an immortalizing oncogene on chr.8q24.3 amplicon, confers intrinsic resistance to cdk4/6 inhibitors in breast cancer” during poster session 2 on Dec. 10.

Additional cancer center researchers with findings included in the poster sessions include Carla Fisher, MD; Miller; Mateusz Opyrchal, MD, PhD; Bryan Schneider, MD; Anna Maria Storniolo, MD; and Rich Zellars, MD. Cancer center trainees Aditi Khatpe and Urja Kamdar are authors on poster session abstracts.